The Psychedelic Therapies Executive Order

Key Points

• This viewpoint aims to address the implications of an executive order on psychedelic drug development and clinical integration.
• Discusses issues surrounding the ethical integration of psychedelic therapies.
• Outlines potential frameworks for the development and approval of psychedelic drugs.
• Analyzes evidence-based approaches for clinical care involving psychedelics.
• Highlights the need for ethical considerations in the application of psychedelic therapies.
• Emphasizes the importance of evidence-based practices in integrating these therapies into clinical settings.